August 2021: Ozempic Associated With Heightened Risk of Diabetic Retinopathy Study results focused on diabetic retinopathy (DR) in patients taking semaglutide found that a higher risk for DR complications were observed with semaglutide in patients with proliferative and non-proliferative DR at baseline. However, researchers do acknowledge that worsening DR can be from rapid drops in blood glucose levels from diabetic medications
no licensed dosing guidance exists for routine clinical use in the UK
Blue Cross Blue Shield : Coverage varies by state
The oral disintegrating tablet formulation may present unique considerations for patients with oral mucosal conditions that could affect proper administration, which should be evaluated by the prescribing provider
Regular Exercise: Aim for at least 150 minutes of moderate-intensity exercise per week, such as brisk walking, cycling, or swimming
Combat GLP-1 and diet-related fatigue The Wegovy (semaglutide) patient information label by Novo Nordisk states that 11% of adults taking Wegovy 2.4 mg experience fatigue, and 8% felt dizzy